United Kingdom (GB)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Adjusting the energy of interfacial states in organic photovoltaics for maximum efficiency (2021) Gasparini N, Camargo FV, Frühwald S, Nagahara T, Classen A, Roland S, Wadsworth A, et al. Journal article Extensions of the SEIR model for the analysis of tailored social distancing and tracing approaches to cope with COVID-19 (2021) Grimm V, Mengel F, Schmidt M Journal article Steady streaming as a method for drug delivery to the inner ear (2021) Sumner L, Mestel J, Reichenbach T Journal article Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth (2021) Munir H, Jones JO, Janowitz T, Hoffmann M, Euler M, Martins CP, Welsh SJ, Shields JD Journal article Novel hybrid method to additively manufacture denser graphite structures using Binder Jetting (2021) Popov V, Fleisher A, Muller-Kamskii G, Shishkin A, Katz-Demyanetz A, Travitzky N, Goel S Journal article Environmental signals rather than layered ontogeny imprint the function of type 2 conventional dendritic cells in young and adult mice (2021) Papaioannou NE, Salei N, Rambichler S, Ravi K, Popovic J, Küntzel V, Lehmann C, et al. Journal article Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation (2021) Polymeris AA, Macha K, Paciaroni M, Wilson D, Koga M, Cappellari M, Schaedelin S, et al. Journal article Ski mountaineering: sports medical considerations for this new Olympic sports (2021) Boesl T, Lutter C, Schöffl V Journal article, Editorial Network medicine for disease module identification and drug repurposing with the NeDRex platform (2021) Sadegh S, Skelton J, Anastasi E, Bernett J, Blumenthal DB, Galindez G, Salgado-Albarran M, et al. Journal article Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) (2021) Coates LC, Gossec L, Theander E, Bergmans P, Neuhold M, Karyekar CS, Shawi M, et al. Journal article